Serum Progesterone as an Admission Prognostic Marker in Male Traumatic Brain Injury Patients

Arundhati Dasgupta, Dipti Sarma, Uma Kaimal Saikia

Abstract


Background: In this prospective study, we analyzed data in men with moderate traumatic brain injury, to find whether higher levels of serum progesterone at admission are associated with better prognosis.

Methods: One hundred male patients of traumatic brain injury, with a postresuscitation Glasgow Coma Scale score between 4 to 12 were enrolled and serum for progesterone collected at admission. Outcome was assessed 30 days postinjury according to Glasgow Outcome Scale (GOS) and Functional Independence Measure (FIM) score.

Results: The mean progesterone level in the group with GOS ≤ 3 was 0.89 ± 033 ng/mL as compared to 1.03 ± 0.18 ng/mL in those with GOS > 3  ( P value 0.1409) and 0.9 ± 0.45 ng/mL in the group with FIM ≤ 4 compared to 1.27 ± 0.32  ng/mL in the group with FIM > 4 (P value 0.0474).

Conclusion: We concluded that lower progesterone levels are associated with poorer outcome measures in male traumatic brain injury patients.




J Neurol Res. 2012;2(2):44-47
doi: https://doi.org/10.4021/jnr101w


Keywords


Brain injury; Progesterone; Prognostic marker

Full Text: HTML PDF
 

Browse  Journals  

 

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

 

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

 

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

 

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

 

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 
       
 

Journal of Neurology Research, biannually, ISSN 1923-2845 (print), 1923-2853 (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.neurores.org   editorial contact: editor@neurores.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.


Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.